Cadwell and Medical Informatics Corp (MIC) announced a strategic partnership integrating neurodiagnostic monitoring with multimodal patient surveillance, marking what the companies position as the first enterprise-grade integration between EEG systems and vendor-neutral clinical platforms. The partnership aims to address persistent data fragmentation challenges that limit clinical teams’ ability to synthesize neurological, cardiac, respiratory, and other physiological signals into unified patient views across critical care environments.
HotSpot Take:
When neurodiagnostic leaders integrate with vendor-neutral platforms, it signals healthcare’s shift from device-centric monitoring to unified clinical intelligence ecosystems—critical infrastructure for AI-ready care delivery.
Under the agreement, Cadwell’s Arc EEG systems will integrate with MIC’s Sickbay Clinical Platform to deliver synchronized multimodal data streams combining neurodiagnostic waveforms with bedside monitors, ventilators, infusion pumps, cameras, laboratory results, and electronic health record data. According to the companies, the integration will enable clinicians to access continuous native-format waveform capture, support remote and tele-neuro monitoring capabilities, and provide streaming near real-time and retrospective data for clinical workflows, quality improvement initiatives, and research applications.
Enterprise-Scale Neurodiagnostic Integration
The partnership addresses a clinical intelligence gap in hospitals where neurodiagnostic data typically remains siloed from broader physiological monitoring systems. Traditional approaches require clinicians to reference multiple disconnected platforms to synthesize neurological status with cardiovascular, respiratory, and metabolic parameters. According to the companies, the integrated solution will provide high-fidelity EEG data alongside other bedside monitoring streams within a single platform architecture designed for AI-readiness and advanced decision support.
“We are excited to innovate with MIC by adding critical EEG data to Sickbay’s monitoring platform to help drive efficient diagnoses and improve efficiencies in health systems.” — Patrick Jensen, PhD, CEO, Cadwell
“We are excited to innovate with MIC by adding critical EEG data to Sickbay’s monitoring platform to help drive efficient diagnoses and improve efficiencies in health systems,” said Patrick Jensen, PhD, CEO of Cadwell.
Continuous EEG monitoring has become increasingly important in intensive care settings, particularly for detecting nonconvulsive status epilepticus and other neurological conditions that lack overt clinical manifestations. Research indicates that longer measurement times substantially improve detection rates, with studies showing detection rates exceeding 80% with 12-hour continuous monitoring for patients with suspected seizure activity. The integration aims to make this neurological intelligence accessible alongside other physiological data streams for more comprehensive patient assessment.
Vendor-Neutral Architecture for Scalability
MIC’s Sickbay platform operates as an FDA-cleared Class II medical device positioning itself as the only vendor-neutral, integrated patient monitoring solution in healthcare. The platform’s Time Series Data Engine consolidates time-sequenced patient monitoring data from multiple device manufacturers, processing data streams with average latency of 25 milliseconds per patient. The vendor-neutral design allows health systems to monitor facilities using different device manufacturers without requiring hardware replacement, potentially reducing technology redundancy and total cost of ownership.
“Clinicians want a complete and continuous picture of every patient. Together with Cadwell, we are giving them the multimodal visibility and intelligence needed to make critical decisions faster.” — Emma Fauss, PhD, CEO, Medical Informatics Corp
“Clinicians want a complete and continuous picture of every patient,” said Emma Fauss, PhD, CEO of MIC. “Together with Cadwell, we are giving them the multimodal visibility and intelligence needed to make critical decisions faster.”
The platform delivers unlimited user access across hospital departments, enabling clinical documentation for compliance and revenue cycle purposes while supporting remote monitoring through laptops, mobile devices, wallboards, and command centers. Previous MIC integrations have incorporated predictive analytics tools including Fifth Eye’s AHI System for hemodynamic instability prediction and various telemetry solutions processing upwards of 60 patients per monitoring station.
Addressing Fragmented Clinical Intelligence
Hospitals face significant operational challenges from fragmented monitoring systems that limit data access, inhibit care team collaboration, and create workflow inefficiencies. Multiple proprietary systems with incompatible data formats force clinicians to navigate disparate interfaces, delaying critical decision-making and potentially affecting patient outcomes. According to the companies, unified data platforms can reduce these barriers while creating infrastructure supporting AI algorithm development and deployment at enterprise scale.
The competitive landscape includes major medical device manufacturers pursuing interoperability through various approaches. Philips Healthcare has integrated its Capsule Medical Device Information Platform with Patient Information Center iX to enable vendor-neutral data streaming, while companies like Ascom offer medical device integration supporting over 80% of market devices. The emergence of Service-oriented Device Connectivity (SDC) standards reflects a broader industry movement toward open ecosystems enabling command and control across device manufacturers.
Point-of-care EEG solutions have also gained traction, with companies like Ceribell developing AI-powered systems specifically for acute care seizure detection. Ceribell’s ClarityPro algorithm secured both FDA Breakthrough Designation and CMS New Technology Add-on Payment reimbursement for diagnosing electrographic status epilepticus, demonstrating regulatory and reimbursement pathways for advanced neurodiagnostic AI applications.
Implementation and Market Positioning
The partnership positions Cadwell and MIC to compete in the growing clinical surveillance and multimodal monitoring market, where healthcare analytics spending is projected to reach $93.3 billion by 2027, according to industry forecasts. Intel Capital has highlighted data siloing as a significant barrier to advanced analytics in healthcare, noting that medical device manufacturers’ proprietary data formats limit flexible, centralized monitoring and AI deployment. Vendor-neutral platforms that unlock time-series vitals and waveform data could enable standardized workflows for real-time AI applications.
For health systems, the value proposition centers on operational efficiency, clinical quality improvement, and research enablement. Consolidated physiological data accessible through single platforms can streamline clinical workflows, reduce documentation burdens, and support population health analytics. The architecture also provides infrastructure for developing and validating clinical decision support algorithms using comprehensive patient datasets spanning multiple physiological domains.
The integration’s success will depend on implementation execution, clinical workflow adoption, and demonstrated outcomes in hospital deployments. Questions remain about integration complexity across diverse hospital IT environments, staff training requirements, and validation of claimed efficiency gains through real-world evidence. Healthcare organizations evaluating multimodal monitoring platforms will likely assess total cost of ownership, interoperability with existing systems, and vendor roadmaps for AI and analytics capabilities.
As healthcare continues its digital transformation, partnerships connecting specialized diagnostic modalities with enterprise clinical platforms represent strategic positioning for the convergence of monitoring, analytics, and AI-driven decision support. For patients, the potential benefit lies in clinicians having more complete physiological intelligence to inform time-sensitive treatment decisions across neurology, critical care, and acute care settings.
This original article was created with AI support.
